Matthew B. Klein, Director: ClearPoint Neuro CLPT Sell · Filed 05/26

Trade details

Type: Insider sale
Amount: $185,440
Shares · price: 16,000 sh · $11.59 a share
Held after: 46,935 sh
Stock: ClearPoint Neuro CLPT
Person: Matthew B. KleinDirector
Trade date: 26/05/21
Filed: 26/05/26
Days to filing: 5 days

Sold 25.4% of holdings

Share of holding sold: 25.4%

ClearPoint Neuro trades, last 26 weeks

What else happened in ClearPoint Neuro around then

Filed or reported within 30 days of the trade day · 04/21~06/20

Matthew B. Klein's recent trades

Matthew B. KleinOfficer, Director
Planned salePTC Therapeutics
Planned sale
PTC Therapeutics
PTCT
$705.8K
10,292 sh
$705.8K
Filed 08/04
Traded 08/04
Matthew B. KleinDirector
Planned saleClearPoint Neuro
Planned sale
ClearPoint Neuro
CLPT
$185.4K
16,000 sh
$185.4K
Filed 05/21
Traded 05/21
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$527.7K
7,221 sh
$527.7K
Filed 05/15
Traded 05/14
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$186.4K
2,572 sh
$186.4K
Filed 05/15
Traded 05/14
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$153.5K
2,100 sh
$153.5K
Filed 05/15
Traded 05/14